glp-1 agonist dpp 4 inhibitor Mechanism of action for GIP, analogues and DPP4 inhibitors in DPP4 Inhibitors vs GLP-1 Agonists
Description
Beyond these headline outcomes, studies also report improvements in blood pressure, cholesterol, and insulin sensitivity, painting a picture of a therapy that supports the bodys entire metabolic system
PMID: 43 YoshijiSIwasakiYIwasakiKMegumiA-AHonjoSWadaYet al
10.3389/fendo.2022.1043789 60 LoombaR.HartmanM
Patients with T2DM experience a significant decline in the incretin function causing delayed and reduced insulin release after glucose administration, impairing glucose tolerance [12,13,14]
YanWCuiXGuoTLiuNWangZSunYet al
